Search Results

You are looking at 1 - 10 of 20 items for :

  • de novo lipogenesis x
Clear All
Leanne Hodson Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospital Trusts, Oxford, UK

Search for other papers by Leanne Hodson in
Google Scholar
PubMed
Close
and
Fredrik Karpe Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospital Trusts, Oxford, UK

Search for other papers by Fredrik Karpe in
Google Scholar
PubMed
Close

hepatic glucose and lipid metabolism by direct and indirect mechanisms ( 1 ). For example portal insulin acts on the liver to directly activate glycogen synthesis and de novo lipogenesis (DNL) and inhibit gluconeogenesis, whilst peripherally insulin may

Open access
Karim Gariani Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals and Geneva University, Geneva, Switzerland

Search for other papers by Karim Gariani in
Google Scholar
PubMed
Close
and
François R Jornayvaz Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals and Geneva University, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Close

of carbohydrates leading to de novo lipogenesis) ( 2 , 13 , 23 , 24 , 25 , 26 ). Nevertheless, some endocrine diseases are also associated with NAFLD and NASH ( Table 1 ), and their pathophysiology will be discussed. Table 1 Endocrine

Open access
Helle Keinicke Insulin and Device Trial Operations, Novo Nordisk A/S, Søborg, Denmark

Search for other papers by Helle Keinicke in
Google Scholar
PubMed
Close
,
Gao Sun Pharmacology and Histopathology, Novo Nordisk A/S, China

Search for other papers by Gao Sun in
Google Scholar
PubMed
Close
,
Caroline M Junker Mentzel Department of Experimental Animal Models, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed
Close
,
Merete Fredholm Department of Veterinary Clinical and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Merete Fredholm in
Google Scholar
PubMed
Close
,
Linu Mary John Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Linu Mary John in
Google Scholar
PubMed
Close
,
Birgitte Andersen Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Birgitte Andersen in
Google Scholar
PubMed
Close
,
Kirsten Raun Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Kirsten Raun in
Google Scholar
PubMed
Close
, and
Marina Kjaergaard Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed
Close

. ( https://doi.org/10.1016/j.cell.2005.12.022 ) 38 Postic C Girard J . Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice . Journal of Clinical Investigation 2008

Open access
Yu Lin State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Yu Lin in
Google Scholar
PubMed
Close
,
Yingying Zhang State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Yingying Zhang in
Google Scholar
PubMed
Close
,
Lei Xu Maternal and Child Health Care Hospital of Dongchangfu District, Liaocheng, People’s Republic of China

Search for other papers by Lei Xu in
Google Scholar
PubMed
Close
,
Wei Long State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Wei Long in
Google Scholar
PubMed
Close
,
Chunjian Shan State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Chunjian Shan in
Google Scholar
PubMed
Close
,
Hongjuan Ding State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Hongjuan Ding in
Google Scholar
PubMed
Close
,
Lianghui You State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Lianghui You in
Google Scholar
PubMed
Close
,
Chun Zhao State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Chun Zhao in
Google Scholar
PubMed
Close
, and
Zhonghua Shi State Key Laboratory of Reproductive Medicine, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, People’s Republic of China

Search for other papers by Zhonghua Shi in
Google Scholar
PubMed
Close

novo lipogenesis ( 21 ). Results of microarray analysis showed that pathways associated with pyruvate metabolism and TCA cycle were down-regulated, meaning that the de novo lipogenesis is suppressed, which in turn leads to the decrease of fat

Open access
Xu Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Xu Chen in
Google Scholar
PubMed
Close
,
Yi Tang Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Yi Tang in
Google Scholar
PubMed
Close
,
Shen Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

Search for other papers by Shen Chen in
Google Scholar
PubMed
Close
,
Wenhua Ling Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Close
, and
Qing Wang Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Qing Wang in
Google Scholar
PubMed
Close

hepatic de novo lipogenesis and may serve as a biomarker of NAFLD progression ( 21 ). Here, we combined two datasets from GSE database and found that hepatic IGFBP-2 expression as a hub gene was also reversely associated with steatosis and serum ALT

Open access
Jana Ernst Department of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse, Halle (Saale), Germany

Search for other papers by Jana Ernst in
Google Scholar
PubMed
Close
,
Katharina Gert Department of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse, Halle (Saale), Germany

Search for other papers by Katharina Gert in
Google Scholar
PubMed
Close
,
Frank Bernhard Kraus Central Laboratory, University Hospital Halle (Saale), Ernst-Grube-Strasse, Halle (Saale), Germany

Search for other papers by Frank Bernhard Kraus in
Google Scholar
PubMed
Close
,
Ulrike Elisabeth Rolle-Kampczyk Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany

Search for other papers by Ulrike Elisabeth Rolle-Kampczyk in
Google Scholar
PubMed
Close
,
Martin Wabitsch Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Close
,
Faramarz Dehghani Department of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse, Halle (Saale), Germany

Search for other papers by Faramarz Dehghani in
Google Scholar
PubMed
Close
, and
Kristina Schaedlich Department of Anatomy and Cell Biology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Grosse Steinstrasse, Halle (Saale), Germany

Search for other papers by Kristina Schaedlich in
Google Scholar
PubMed
Close

an enzyme machinery enabling them for the de novo synthesis of steroid hormones from cholesterol ( 8 ). Androgenic steroids exhibit a positive gradient from blood to adipose tissue with the precursor androstenedione and dehydroepiandrosterone as

Open access
Kennett Sprogøe Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Kennett Sprogøe in
Google Scholar
PubMed
Close
,
Eva Mortensen Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Close
,
David B Karpf Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by David B Karpf in
Google Scholar
PubMed
Close
, and
Jonathan A Leff Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
Close

in China Pfizer, Inc. PHA-794428 Permanently PEGylated GH Discontinued Novo Nordisk A/S NNCl126-0083 Permanently PEGylated GH Discontinued Ambrx, Inc. ARX201 Permanently PEGylated and mutated GH Discontinued Teva

Open access
Huixing Liu Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Huixing Liu in
Google Scholar
PubMed
Close
and
Daoquan Peng Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Search for other papers by Daoquan Peng in
Google Scholar
PubMed
Close

hypothyroidism. The altered functions are labeled in the presence of hypothyroidism. Red arrows mark actions of declined TH, and blue arrows mark actions of elevated TSH. TH decreases in hypothyroidism and then de novo lipogenesis (DNL) and the activity of HMG

Open access
Peter Wolf Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed
Close
,
Yvonne Winhofer Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed
Close
,
Martin Krššák Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria

Search for other papers by Martin Krššák in
Google Scholar
PubMed
Close
, and
Michael Krebs Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Michael Krebs in
Google Scholar
PubMed
Close

hyperlipidemia, hyperinsulinemia and hyperglycemia ( 71 ). It remains to be investigated whether this is due to increased lipid oxidation promoted by GH and IGF-1 or due to alterations in hepatic lipid metabolism, i.e. de novo lipogenesis and lipolysis

Open access
Anastasia P Athanasoulia-Kaspar Max Planck Institute of Psychiatry, Department of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany

Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Close
,
Kathrin H Popp Max Planck Institute of Psychiatry, Department of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany

Search for other papers by Kathrin H Popp in
Google Scholar
PubMed
Close
, and
Gunter Karl Stalla Max Planck Institute of Psychiatry, Department of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany

Search for other papers by Gunter Karl Stalla in
Google Scholar
PubMed
Close

characterized by the maladaptive nature of the preoccupations and the inability of the subject to control these urges, and they mainly have a de novo onset after the initiation of the DA on the basis of a negative psychiatric history. Whereas the overall

Open access